BTTX (Better Therapeutics) Inventories, Raw Materials & Components: $0.00 Mil (As of Sep. 2023)


What is Better Therapeutics Inventories, Raw Materials & Components?

Better Therapeutics BTTX Inventories, Raw Materials & Components is $0.00 Mil as of Sep. 2023.

Better Therapeutics's inventories, raw materials & components for the quarter that ended in Sep. 2023 was $0.00 Mil.

Better Therapeutics Inventories, Raw Materials & Components Historical Data

* Premium members only.

The historical data trend for Better Therapeutics's Inventories, Raw Materials & Components can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Better Therapeutics Inventories, Raw Materials & Components Chart

Better Therapeutics Annual Data
Trend Dec19 Dec20 Dec21 Dec22
Inventories, Raw Materials & Components
0.00 0.00 0.00 0.00

Better Therapeutics Quarterly Data
Dec19 Jun20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
Inventories, Raw Materials & Components Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Better Therapeutics Inventories, Raw Materials & Components Calculation

Materials and components scheduled for use in making a product.

What does a Inventories, Raw Materials & Components of $0.00 Mil mean?
Better Therapeutics (BTTX) has a Inventories, Raw Materials & Components of $0.00 Mil as of Sep. 2023. Raw materials are the components a company uses for its main products. View historical data on Better Therapeutics and its competitors.
Is Better Therapeutics' Inventories, Raw Materials & Components too high?
Better Therapeutics' current Inventories, Raw Materials & Components is $0.00 Mil.
How does Better Therapeutics' Inventories, Raw Materials & Components compare to CYCN and CELZ?
Better Therapeutics' Inventories, Raw Materials & Components of $0.00 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Inventories, Raw Materials & Components for a Biotechnology company?
A good Inventories, Raw Materials & Components depends on the Biotechnology industry context. However, Inventories, Raw Materials & Components should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Inventories, Raw Materials & Components mean?
A high Inventories, Raw Materials & Components can signal that a stock is expensive relative to its fundamentals. Raw materials are the components a company uses for its main products. View historical data on Better Therapeutics and its competitors. Better Therapeutics's current Inventories, Raw Materials & Components is $0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Better Therapeutics stock overvalued right now?
Better Therapeutics (BTTX) has a current Inventories, Raw Materials & Components of $0.00 Mil. The current Inventories, Raw Materials & Components is $0.00 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Inventories, Raw Materials & Components calculated?
Inventories, Raw Materials & Components is calculated from a company's financial statements. For Better Therapeutics (BTTX), the current Inventories, Raw Materials & Components is $0.00 Mil as of Sep. 2023. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Better Therapeutics Business Description

Address 548 Market Street, Suite 49404, San Francisco, CA, USA, 94104
Better Therapeutics Inc is a prescription digital therapeutics company developing a novel form of cognitive behavioural therapy to address the root causes of cardiometabolic diseases. The company has developed a proprietary platform for the development of FDA-regulated, software-based solutions for type 2 diabetes, heart disease and other conditions.